Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Could There Finally Be an Effective Treatment for Alzheimer's Disease?

ProMIS' preclinical treatment could possibly outshine Biogen's candidate. Finding an effective treatment for Alzheimer's disease has been elusive as many seemingly promising avenues of research did not prove out in clinical trials. Biogen Inc. (BIIB:NASDAQ) appeared...

Biopharma Reports Consistent 'Phase 2 Liver Fat (NASH and NAFLD) Results'

The new data are reviewed and updates are provided on Can-Fite BioPharma's other clinical studies, including one for COVID-19, in this Dawson James research report. In an April 20 research note, Dawson James analyst Jason Kolbert wrote that results from Can...

How This Junior Exploration Company Sits in one of the World’s Highest-Grade Silver Districts

The silver market is back with Scotiabank’s silver price prediction for 2022 to maintain an average price of $24.50 per ounce. Metallic Minerals ( TSXV:MMG , OTCQB:MMNGF , Forum ) – a Metallic Group Company – is a Canadian exploration that is f...

Visionary Vicissitude

It was one of those days that all sexagenarians loathe; you have to go to the doctor, and whether it's the GP (general practitioner) or the dentist or the proctologist, nothing reminds you more rapidly of your advancing age than going to the optometrist. Now, many of ...

Cracking the Code to Society’s Most Feared Disease

Even more so than cancer, it’s the one disease that we all fear the most. The thought of falling prey to Alzheimer’s disease and to the inevitable desecration of our mind is something that makes even the bravest among us shudder. ...

Ahead of the Competition and Poised for Ridesharing Growth

Many expected the ridesharing sector to struggle during the COVID-19 pandemic. Instead, investors are finding that some companies have actually thrived. In the micro-mobility space specifically, one company's unique business model has allowed it to see business increase. ...

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously

We are initiating coverage on INmune Bio Inc. (INMB:NASDAQ) . According to the company, INmune is "Reprogramming the Innate Immune System for the Treatment of Diseases." On the surface, this sounds like a fairly standard biotech tagline, but there's a more here than me...

This Gold & Silver Exploration Company is Drilling THIS Summer in BC’s Golden Triangle

Six months after news of the COVID-19 virus first broke, financial markets around the world are finally starting to shake off the dust. And while a sense of normality may be starting to return, the blows it dealt will likely result in a few resilient bruises. Like the ov...

SunPower (SPWRA): Retreating into familiar territory

Last week, SunPower Corporation ( NASDAQ: SPWRA , Stock Forum ) updated its 2011 guidance, predicting that ex-items earnings per share would range between $1.75 and $2.05. Revenue for the upcoming fiscal year is predicted to arrive between $2.65 billion and $2.85 billion....

E*Trade Financial (ETFC): Will the stock run into an options wall?

Online brokerage house E*Trade Financial Corporation ( NASDAQ: ETFC , Stock Forum ) announced on Friday that Chief Financial Officer Bruce Nolop will step down from his post at the end of the year. Nolop, who has served as CFO since 2008, will be succeeded by Matthew Aude...
1 2 3 4 5 6 7 8 9 10 ...